About this trial
The goal of this study is to evaluate the sensitivity of a newly-developed prototype device in its ability to measure brain responses to speech sounds in an infant population. The main research questions are: 1) Is the prototype sensitive to brain response differences from infants with hearing loss with and without hearing aids? and 2) How do the measured brain responses from infants with hearing loss compare to infants with normal hearing who are the same age? Participants will have their brain responses measured using the prototype in response to average-level non-sense speech sounds across 1 to 2 sessions in a "no-hearing aids" condition. Participants with hearing loss who are already fit with hearing aids will additionally undergo a "with hearing aids" recording condition.
Eligibility criteria
Qualifiers
Infants (3 to 24 months of age) with normal hearing who have passed their audiological diagnostic evaluation
Infants (3 to 24 months of age) identified with hearing loss at their audiological diagnostic evaluation, whose parents have chosen spoken language as their form of communication, and who have been prescribed and fitted with a hearing aid(s).
Disqualifiers
None
Trial design
Treatments tested in this trial
- A newly developed prototype device for speech-evoked EFR Measurement
Treatment groups
Sponsors and collaborators
Susan Scollie
Lead sponsor
Western University, Canada
Sponsor institution
Dalhousie University
Collaborator